Standex (SXI) director logs small 50-share planned stock sale at $268.43
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Standex International director Thomas E. Chorman reported a small open-market sale of company stock. On this Form 4, he sold 50 shares of Standex International common stock at an average price of $268.43 per share on May 1, 2026, and held 12,516 shares afterward. The filing notes that this sale was made under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating the transaction was pre-planned rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 50 shares ($13,422)
Net Sell
1 txn
Insider
CHORMAN THOMAS E
Role
null
Sold
50 shs ($13K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 50 | $268.43 | $13K |
Holdings After Transaction:
Common Stock — 12,516 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares sold: 50 shares
Sale price: $268.43 per share
Shares held after sale: 12,516 shares
3 metrics
Shares sold
50 shares
Open-market sale on May 1, 2026
Sale price
$268.43 per share
Average sale price for the 50 shares
Shares held after sale
12,516 shares
Direct holdings following the transaction
Key Terms
Rule 10b5-1 trading plan, open-market sale, Common Stock, Form 4
4 terms
Rule 10b5-1 trading plan regulatory
"Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did SXI director Thomas E. Chorman report?
Thomas E. Chorman reported an open-market sale of 50 shares of Standex International (SXI) common stock. The shares were sold at an average price of $268.43 each, and the transaction was disclosed on a Form 4 insider trading report filed with regulators.
Was the SXI insider sale made under a Rule 10b5-1 trading plan?
Yes. The Form 4 footnote states the 50-share sale was executed under an existing Rule 10b5-1 trading plan dated November 6, 2025. Such pre-arranged plans are established in advance and are typically used to automate insider share sales over time.
What type of security did Thomas E. Chorman trade in this SXI Form 4?
The transaction involved Standex International common stock, classified as a non-derivative security. No options or other derivatives were reported, and the filing does not show any remaining derivative positions for Chorman after this specific sale.